Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan

v3.22.2.2
Equity Incentive Plan
6 Months Ended
Jun. 30, 2022
Equity Incentive Plan  
Equity Incentive Plan

Note 8 — Equity Incentive Plan

In May 2013, the Company adopted the 2013 Equity Incentive Plan (as amended and restated, the “Plan”) and reserved shares of common stock for issuance under the Plan, which was last amended in June 2021. The Plan is administered by the Compensation Committee of the Company’s Board of Directors (the “Board”). At June 30, 2022, 394,979 shares of common stock were available for issuance under the Plan.

A summary of the Company’s stock option activity and related information is as follows:

Weighted

Weighted

Average

Average

Remaining

Stock

Exercise

Life

    

Options

    

Price

    

(in years)

Outstanding at December 31, 2021

 

492,886

$

7.35

 

7.6

Granted

 

41,062

$

10.32

 

Exercised

 

(3,750)

$

5.36

 

Forfeited

(16,250)

$

9.33

Outstanding at June 30, 2022

 

513,948

$

7.54

 

7.0

Exercisable at June 30, 2022

 

404,426

$

6.64

 

6.5

During the six months ended June 30, 2022, the Company granted 31,062 stock options to Board members and 10,000 stock options to employees under the Plan. The estimated fair value of these stock options, calculated using the Black-Scholes option valuation model, was $305,890, of which $105,488 was recognized during the six months ended June 30, 2022.

In January 2022, the Compensation Committee of the Board approved a modification of stock option grants to David Eisenhaure, the Company’s former Chairman of the Board, who passed away in October 2021. The modification extended the post-termination exercise period of his vested stock option grants from 12 months to 5 years. During the six months ended June 30, 2022, the Company recognized $49,327 of expense related to this modification.

At June 30, 2022 and December 31, 2021, there were 100,000 unvested restricted stock units (“RSUs”) outstanding. No RSUs were granted, vested or forfeited during the six months ended June 30, 2022.

At June 30, 2022, there was $1,539,738 of unrecognized compensation cost related to non-vested equity awards granted under the Plan. That cost is expected to be recognized over a weighted average period of 1.1 years.